Related Experiment Videos
Current status of pharmacotherapy for PTSD: an effect size analysis of controlled studies
S J Penava1, M W Otto, M H Pollack
1Massachusetts General Hospital, Boston 02114, USA.
Depression and Anxiety
|January 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Brain connectomics predict response to treatment in social anxiety disorder.
Molecular psychiatry·2015
The role of anxiety sensitivity in sleep disturbance in panic disorder.
Journal of anxiety disorders·2011
Personality and bipolar disorder: dissecting state and trait associations between mood and personality.
Psychological medicine·2010
Child-To-Adult Body Size Change and Risk of Depression and Anxiety: A Large Prospective Cohort Study.
Depression and anxiety·2026
Mental Health Crisis Among Married Women in Bangladesh: Risk Factors and the Role of Misdiagnosis.
Depression and anxiety·2026
Multi-database pharmacovigilance identifies disproportionate reporting of hepatobiliary events with avacopan: an integrative study with network pharmacology and interpretable machine learning.
Naunyn-Schmiedeberg's archives of pharmacology·2026
AI-Guided Discovery of Natural-Product-Inspired Scaffolds as Dual P-gp/BCRP Inhibitors to Overcome Cancer Multidrug Resistance.
Journal of medicinal chemistry·2026
Real-world outcomes of sitagliptin and sitagliptin/metformin single-pill combination treatment in diverse type 2 diabetes populations (DIVERSITY study).
Frontiers in clinical diabetes and healthcare·2026
Polypharmacy status and its related risk factors among elderly patients with dyslipidemia: Iranian multi-center osteoporosis study (IMOS) 2021.
Journal of diabetes and metabolic disorders·2026